Global Lung Cancer Genomic Testing Market Research Report 2025(Status and Outlook)
Lung cancer genomic testing, also referred to as molecular profiling or biomarker testing, involves the analysis of tumor tissue or blood samples to identify specific genetic mutations, alterations, or biomarkers?such as EGFR, ALK, ROS1, BRAF, MET, and KRAS?that drive cancer growth, inform prognosis, and guide treatment decisions by matching patients with targeted therapies or immunotherapies. This testing is an integral component of precision oncology, enabling personalized treatment strategies that improve outcomes by focusing on the molecular characteristics of an individual's cancer rather than applying a one-size-fits-all approach.
The global Lung Cancer Genomic Testing market size was estimated at USD 1285.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lung Cancer Genomic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lung Cancer Genomic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lung Cancer Genomic Testing market.
Global Lung Cancer Genomic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CD Genomics
Qiagen NV
Laboratory Corporation of America Holdings
NeoGenomics Laboratories
Agilent Technologies Inc.
Illumina Inc.
Thermo Fischer Scientific Inc.
Abbott Laboratories Inc.
Quest Diagnostics Inc.
OncoDNA
Centogene N.V.
Admera Health
CeGaT GmbH
OPKO Health Inc.
F. Hoffmann-La Roche AG.
Market Segmentation (by Type)
Liquid Biopsy
Tissue Biopsy
Market Segmentation (by Application)
Hospitals/Clinics
Research Organization
Diagnostic Laboratories
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Lung Cancer Genomic Testing Market
Overview of the regional outlook of the Lung Cancer Genomic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Genomic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Genomic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Lung Cancer Genomic Testing market size was estimated at USD 1285.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lung Cancer Genomic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lung Cancer Genomic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lung Cancer Genomic Testing market.
Global Lung Cancer Genomic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CD Genomics
Qiagen NV
Laboratory Corporation of America Holdings
NeoGenomics Laboratories
Agilent Technologies Inc.
Illumina Inc.
Thermo Fischer Scientific Inc.
Abbott Laboratories Inc.
Quest Diagnostics Inc.
OncoDNA
Centogene N.V.
Admera Health
CeGaT GmbH
OPKO Health Inc.
F. Hoffmann-La Roche AG.
Market Segmentation (by Type)
Liquid Biopsy
Tissue Biopsy
Market Segmentation (by Application)
Hospitals/Clinics
Research Organization
Diagnostic Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Lung Cancer Genomic Testing Market
Overview of the regional outlook of the Lung Cancer Genomic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Genomic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Genomic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Genomic Testing
1.2 Key Market Segments
1.2.1 Lung Cancer Genomic Testing Segment by Type
1.2.2 Lung Cancer Genomic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER GENOMIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Genomic Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Genomic Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER GENOMIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Genomic Testing Product Life Cycle
3.3 Global Lung Cancer Genomic Testing Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Genomic Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Genomic Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Lung Cancer Genomic Testing Market Competitive Situation and Trends
3.8.1 Lung Cancer Genomic Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Genomic Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER GENOMIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Genomic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER GENOMIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lung Cancer Genomic Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Lung Cancer Genomic Testing Market
5.7 ESG Ratings of Leading Companies
6 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Genomic Testing Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Genomic Testing Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Genomic Testing Price by Type (2020-2025)
7 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Genomic Testing Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Genomic Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER GENOMIC TESTING MARKET SALES BY REGION
8.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.2 Global Lung Cancer Genomic Testing Sales Market Share by Region
8.2 Global Lung Cancer Genomic Testing Market Size by Region
8.2.1 Global Lung Cancer Genomic Testing Market Size by Region
8.2.2 Global Lung Cancer Genomic Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Genomic Testing Sales by Country
8.3.2 North America Lung Cancer Genomic Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Genomic Testing Sales by Country
8.4.2 Europe Lung Cancer Genomic Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Genomic Testing Sales by Region
8.5.2 Asia Pacific Lung Cancer Genomic Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Genomic Testing Sales by Country
8.6.2 South America Lung Cancer Genomic Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Genomic Testing Sales by Region
8.7.2 Middle East and Africa Lung Cancer Genomic Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER GENOMIC TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Genomic Testing by Region(2020-2025)
9.2 Global Lung Cancer Genomic Testing Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Genomic Testing Production
9.4.1 North America Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Genomic Testing Production
9.5.1 Europe Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Genomic Testing Production (2020-2025)
9.6.1 Japan Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Genomic Testing Production (2020-2025)
9.7.1 China Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CD Genomics
10.1.1 CD Genomics Basic Information
10.1.2 CD Genomics Lung Cancer Genomic Testing Product Overview
10.1.3 CD Genomics Lung Cancer Genomic Testing Product Market Performance
10.1.4 CD Genomics Business Overview
10.1.5 CD Genomics SWOT Analysis
10.1.6 CD Genomics Recent Developments
10.2 Qiagen NV
10.2.1 Qiagen NV Basic Information
10.2.2 Qiagen NV Lung Cancer Genomic Testing Product Overview
10.2.3 Qiagen NV Lung Cancer Genomic Testing Product Market Performance
10.2.4 Qiagen NV Business Overview
10.2.5 Qiagen NV SWOT Analysis
10.2.6 Qiagen NV Recent Developments
10.3 Laboratory Corporation of America Holdings
10.3.1 Laboratory Corporation of America Holdings Basic Information
10.3.2 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
10.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Market Performance
10.3.4 Laboratory Corporation of America Holdings Business Overview
10.3.5 Laboratory Corporation of America Holdings SWOT Analysis
10.3.6 Laboratory Corporation of America Holdings Recent Developments
10.4 NeoGenomics Laboratories
10.4.1 NeoGenomics Laboratories Basic Information
10.4.2 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
10.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Market Performance
10.4.4 NeoGenomics Laboratories Business Overview
10.4.5 NeoGenomics Laboratories Recent Developments
10.5 Agilent Technologies Inc.
10.5.1 Agilent Technologies Inc. Basic Information
10.5.2 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
10.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Market Performance
10.5.4 Agilent Technologies Inc. Business Overview
10.5.5 Agilent Technologies Inc. Recent Developments
10.6 Illumina Inc.
10.6.1 Illumina Inc. Basic Information
10.6.2 Illumina Inc. Lung Cancer Genomic Testing Product Overview
10.6.3 Illumina Inc. Lung Cancer Genomic Testing Product Market Performance
10.6.4 Illumina Inc. Business Overview
10.6.5 Illumina Inc. Recent Developments
10.7 Thermo Fischer Scientific Inc.
10.7.1 Thermo Fischer Scientific Inc. Basic Information
10.7.2 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
10.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Market Performance
10.7.4 Thermo Fischer Scientific Inc. Business Overview
10.7.5 Thermo Fischer Scientific Inc. Recent Developments
10.8 Abbott Laboratories Inc.
10.8.1 Abbott Laboratories Inc. Basic Information
10.8.2 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
10.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Market Performance
10.8.4 Abbott Laboratories Inc. Business Overview
10.8.5 Abbott Laboratories Inc. Recent Developments
10.9 Quest Diagnostics Inc.
10.9.1 Quest Diagnostics Inc. Basic Information
10.9.2 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
10.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Market Performance
10.9.4 Quest Diagnostics Inc. Business Overview
10.9.5 Quest Diagnostics Inc. Recent Developments
10.10 OncoDNA
10.10.1 OncoDNA Basic Information
10.10.2 OncoDNA Lung Cancer Genomic Testing Product Overview
10.10.3 OncoDNA Lung Cancer Genomic Testing Product Market Performance
10.10.4 OncoDNA Business Overview
10.10.5 OncoDNA Recent Developments
10.11 Centogene N.V.
10.11.1 Centogene N.V. Basic Information
10.11.2 Centogene N.V. Lung Cancer Genomic Testing Product Overview
10.11.3 Centogene N.V. Lung Cancer Genomic Testing Product Market Performance
10.11.4 Centogene N.V. Business Overview
10.11.5 Centogene N.V. Recent Developments
10.12 Admera Health
10.12.1 Admera Health Basic Information
10.12.2 Admera Health Lung Cancer Genomic Testing Product Overview
10.12.3 Admera Health Lung Cancer Genomic Testing Product Market Performance
10.12.4 Admera Health Business Overview
10.12.5 Admera Health Recent Developments
10.13 CeGaT GmbH
10.13.1 CeGaT GmbH Basic Information
10.13.2 CeGaT GmbH Lung Cancer Genomic Testing Product Overview
10.13.3 CeGaT GmbH Lung Cancer Genomic Testing Product Market Performance
10.13.4 CeGaT GmbH Business Overview
10.13.5 CeGaT GmbH Recent Developments
10.14 OPKO Health Inc.
10.14.1 OPKO Health Inc. Basic Information
10.14.2 OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
10.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Product Market Performance
10.14.4 OPKO Health Inc. Business Overview
10.14.5 OPKO Health Inc. Recent Developments
10.15 F. Hoffmann-La Roche AG.
10.15.1 F. Hoffmann-La Roche AG. Basic Information
10.15.2 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
10.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Market Performance
10.15.4 F. Hoffmann-La Roche AG. Business Overview
10.15.5 F. Hoffmann-La Roche AG. Recent Developments
11 LUNG CANCER GENOMIC TESTING MARKET FORECAST BY REGION
11.1 Global Lung Cancer Genomic Testing Market Size Forecast
11.2 Global Lung Cancer Genomic Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Genomic Testing Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region
11.2.4 South America Lung Cancer Genomic Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Genomic Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Genomic Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Genomic Testing by Type (2026-2033)
12.1.2 Global Lung Cancer Genomic Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Genomic Testing by Type (2026-2033)
12.2 Global Lung Cancer Genomic Testing Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Genomic Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Genomic Testing
1.2 Key Market Segments
1.2.1 Lung Cancer Genomic Testing Segment by Type
1.2.2 Lung Cancer Genomic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER GENOMIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Genomic Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Genomic Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER GENOMIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Genomic Testing Product Life Cycle
3.3 Global Lung Cancer Genomic Testing Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Genomic Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Genomic Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Lung Cancer Genomic Testing Market Competitive Situation and Trends
3.8.1 Lung Cancer Genomic Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Genomic Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER GENOMIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Genomic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER GENOMIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lung Cancer Genomic Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Lung Cancer Genomic Testing Market
5.7 ESG Ratings of Leading Companies
6 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Genomic Testing Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Genomic Testing Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Genomic Testing Price by Type (2020-2025)
7 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Genomic Testing Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Genomic Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER GENOMIC TESTING MARKET SALES BY REGION
8.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.2 Global Lung Cancer Genomic Testing Sales Market Share by Region
8.2 Global Lung Cancer Genomic Testing Market Size by Region
8.2.1 Global Lung Cancer Genomic Testing Market Size by Region
8.2.2 Global Lung Cancer Genomic Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Genomic Testing Sales by Country
8.3.2 North America Lung Cancer Genomic Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Genomic Testing Sales by Country
8.4.2 Europe Lung Cancer Genomic Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Genomic Testing Sales by Region
8.5.2 Asia Pacific Lung Cancer Genomic Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Genomic Testing Sales by Country
8.6.2 South America Lung Cancer Genomic Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Genomic Testing Sales by Region
8.7.2 Middle East and Africa Lung Cancer Genomic Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER GENOMIC TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Genomic Testing by Region(2020-2025)
9.2 Global Lung Cancer Genomic Testing Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Genomic Testing Production
9.4.1 North America Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Genomic Testing Production
9.5.1 Europe Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Genomic Testing Production (2020-2025)
9.6.1 Japan Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Genomic Testing Production (2020-2025)
9.7.1 China Lung Cancer Genomic Testing Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Genomic Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CD Genomics
10.1.1 CD Genomics Basic Information
10.1.2 CD Genomics Lung Cancer Genomic Testing Product Overview
10.1.3 CD Genomics Lung Cancer Genomic Testing Product Market Performance
10.1.4 CD Genomics Business Overview
10.1.5 CD Genomics SWOT Analysis
10.1.6 CD Genomics Recent Developments
10.2 Qiagen NV
10.2.1 Qiagen NV Basic Information
10.2.2 Qiagen NV Lung Cancer Genomic Testing Product Overview
10.2.3 Qiagen NV Lung Cancer Genomic Testing Product Market Performance
10.2.4 Qiagen NV Business Overview
10.2.5 Qiagen NV SWOT Analysis
10.2.6 Qiagen NV Recent Developments
10.3 Laboratory Corporation of America Holdings
10.3.1 Laboratory Corporation of America Holdings Basic Information
10.3.2 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
10.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Market Performance
10.3.4 Laboratory Corporation of America Holdings Business Overview
10.3.5 Laboratory Corporation of America Holdings SWOT Analysis
10.3.6 Laboratory Corporation of America Holdings Recent Developments
10.4 NeoGenomics Laboratories
10.4.1 NeoGenomics Laboratories Basic Information
10.4.2 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
10.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Market Performance
10.4.4 NeoGenomics Laboratories Business Overview
10.4.5 NeoGenomics Laboratories Recent Developments
10.5 Agilent Technologies Inc.
10.5.1 Agilent Technologies Inc. Basic Information
10.5.2 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
10.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Market Performance
10.5.4 Agilent Technologies Inc. Business Overview
10.5.5 Agilent Technologies Inc. Recent Developments
10.6 Illumina Inc.
10.6.1 Illumina Inc. Basic Information
10.6.2 Illumina Inc. Lung Cancer Genomic Testing Product Overview
10.6.3 Illumina Inc. Lung Cancer Genomic Testing Product Market Performance
10.6.4 Illumina Inc. Business Overview
10.6.5 Illumina Inc. Recent Developments
10.7 Thermo Fischer Scientific Inc.
10.7.1 Thermo Fischer Scientific Inc. Basic Information
10.7.2 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
10.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Market Performance
10.7.4 Thermo Fischer Scientific Inc. Business Overview
10.7.5 Thermo Fischer Scientific Inc. Recent Developments
10.8 Abbott Laboratories Inc.
10.8.1 Abbott Laboratories Inc. Basic Information
10.8.2 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
10.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Market Performance
10.8.4 Abbott Laboratories Inc. Business Overview
10.8.5 Abbott Laboratories Inc. Recent Developments
10.9 Quest Diagnostics Inc.
10.9.1 Quest Diagnostics Inc. Basic Information
10.9.2 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
10.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Market Performance
10.9.4 Quest Diagnostics Inc. Business Overview
10.9.5 Quest Diagnostics Inc. Recent Developments
10.10 OncoDNA
10.10.1 OncoDNA Basic Information
10.10.2 OncoDNA Lung Cancer Genomic Testing Product Overview
10.10.3 OncoDNA Lung Cancer Genomic Testing Product Market Performance
10.10.4 OncoDNA Business Overview
10.10.5 OncoDNA Recent Developments
10.11 Centogene N.V.
10.11.1 Centogene N.V. Basic Information
10.11.2 Centogene N.V. Lung Cancer Genomic Testing Product Overview
10.11.3 Centogene N.V. Lung Cancer Genomic Testing Product Market Performance
10.11.4 Centogene N.V. Business Overview
10.11.5 Centogene N.V. Recent Developments
10.12 Admera Health
10.12.1 Admera Health Basic Information
10.12.2 Admera Health Lung Cancer Genomic Testing Product Overview
10.12.3 Admera Health Lung Cancer Genomic Testing Product Market Performance
10.12.4 Admera Health Business Overview
10.12.5 Admera Health Recent Developments
10.13 CeGaT GmbH
10.13.1 CeGaT GmbH Basic Information
10.13.2 CeGaT GmbH Lung Cancer Genomic Testing Product Overview
10.13.3 CeGaT GmbH Lung Cancer Genomic Testing Product Market Performance
10.13.4 CeGaT GmbH Business Overview
10.13.5 CeGaT GmbH Recent Developments
10.14 OPKO Health Inc.
10.14.1 OPKO Health Inc. Basic Information
10.14.2 OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
10.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Product Market Performance
10.14.4 OPKO Health Inc. Business Overview
10.14.5 OPKO Health Inc. Recent Developments
10.15 F. Hoffmann-La Roche AG.
10.15.1 F. Hoffmann-La Roche AG. Basic Information
10.15.2 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
10.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Market Performance
10.15.4 F. Hoffmann-La Roche AG. Business Overview
10.15.5 F. Hoffmann-La Roche AG. Recent Developments
11 LUNG CANCER GENOMIC TESTING MARKET FORECAST BY REGION
11.1 Global Lung Cancer Genomic Testing Market Size Forecast
11.2 Global Lung Cancer Genomic Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Genomic Testing Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region
11.2.4 South America Lung Cancer Genomic Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Genomic Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Genomic Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Genomic Testing by Type (2026-2033)
12.1.2 Global Lung Cancer Genomic Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Genomic Testing by Type (2026-2033)
12.2 Global Lung Cancer Genomic Testing Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Genomic Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Genomic Testing Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Genomic Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Genomic Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Genomic Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2024)
Table 10. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Lung Cancer Genomic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Genomic Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Lung Cancer Genomic Testing Sales by Type (K Units)
Table 26. Global Lung Cancer Genomic Testing Market Size by Type (M USD)
Table 27. Global Lung Cancer Genomic Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Lung Cancer Genomic Testing Sales Market Share by Type (2020-2025)
Table 29. Global Lung Cancer Genomic Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Lung Cancer Genomic Testing Market Size Share by Type (2020-2025)
Table 31. Global Lung Cancer Genomic Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Lung Cancer Genomic Testing Sales (K Units) by Application
Table 33. Global Lung Cancer Genomic Testing Market Size by Application
Table 34. Global Lung Cancer Genomic Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Lung Cancer Genomic Testing Sales Market Share by Application (2020-2025)
Table 36. Global Lung Cancer Genomic Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Lung Cancer Genomic Testing Market Share by Application (2020-2025)
Table 38. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Lung Cancer Genomic Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Lung Cancer Genomic Testing Sales Market Share by Region (2020-2025)
Table 41. Global Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Lung Cancer Genomic Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Lung Cancer Genomic Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Lung Cancer Genomic Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Lung Cancer Genomic Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Lung Cancer Genomic Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Lung Cancer Genomic Testing Production (K Units) by Region(2020-2025)
Table 54. Global Lung Cancer Genomic Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Lung Cancer Genomic Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. CD Genomics Basic Information
Table 62. CD Genomics Lung Cancer Genomic Testing Product Overview
Table 63. CD Genomics Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. CD Genomics Business Overview
Table 65. CD Genomics SWOT Analysis
Table 66. CD Genomics Recent Developments
Table 67. Qiagen NV Basic Information
Table 68. Qiagen NV Lung Cancer Genomic Testing Product Overview
Table 69. Qiagen NV Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Qiagen NV Business Overview
Table 71. Qiagen NV SWOT Analysis
Table 72. Qiagen NV Recent Developments
Table 73. Laboratory Corporation of America Holdings Basic Information
Table 74. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
Table 75. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Laboratory Corporation of America Holdings Business Overview
Table 77. Laboratory Corporation of America Holdings SWOT Analysis
Table 78. Laboratory Corporation of America Holdings Recent Developments
Table 79. NeoGenomics Laboratories Basic Information
Table 80. NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
Table 81. NeoGenomics Laboratories Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. NeoGenomics Laboratories Business Overview
Table 83. NeoGenomics Laboratories Recent Developments
Table 84. Agilent Technologies Inc. Basic Information
Table 85. Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
Table 86. Agilent Technologies Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Agilent Technologies Inc. Business Overview
Table 88. Agilent Technologies Inc. Recent Developments
Table 89. Illumina Inc. Basic Information
Table 90. Illumina Inc. Lung Cancer Genomic Testing Product Overview
Table 91. Illumina Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Illumina Inc. Business Overview
Table 93. Illumina Inc. Recent Developments
Table 94. Thermo Fischer Scientific Inc. Basic Information
Table 95. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
Table 96. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Thermo Fischer Scientific Inc. Business Overview
Table 98. Thermo Fischer Scientific Inc. Recent Developments
Table 99. Abbott Laboratories Inc. Basic Information
Table 100. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
Table 101. Abbott Laboratories Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Abbott Laboratories Inc. Business Overview
Table 103. Abbott Laboratories Inc. Recent Developments
Table 104. Quest Diagnostics Inc. Basic Information
Table 105. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
Table 106. Quest Diagnostics Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Quest Diagnostics Inc. Business Overview
Table 108. Quest Diagnostics Inc. Recent Developments
Table 109. OncoDNA Basic Information
Table 110. OncoDNA Lung Cancer Genomic Testing Product Overview
Table 111. OncoDNA Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. OncoDNA Business Overview
Table 113. OncoDNA Recent Developments
Table 114. Centogene N.V. Basic Information
Table 115. Centogene N.V. Lung Cancer Genomic Testing Product Overview
Table 116. Centogene N.V. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Centogene N.V. Business Overview
Table 118. Centogene N.V. Recent Developments
Table 119. Admera Health Basic Information
Table 120. Admera Health Lung Cancer Genomic Testing Product Overview
Table 121. Admera Health Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Admera Health Business Overview
Table 123. Admera Health Recent Developments
Table 124. CeGaT GmbH Basic Information
Table 125. CeGaT GmbH Lung Cancer Genomic Testing Product Overview
Table 126. CeGaT GmbH Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. CeGaT GmbH Business Overview
Table 128. CeGaT GmbH Recent Developments
Table 129. OPKO Health Inc. Basic Information
Table 130. OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
Table 131. OPKO Health Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. OPKO Health Inc. Business Overview
Table 133. OPKO Health Inc. Recent Developments
Table 134. F. Hoffmann-La Roche AG. Basic Information
Table 135. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
Table 136. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. F. Hoffmann-La Roche AG. Business Overview
Table 138. F. Hoffmann-La Roche AG. Recent Developments
Table 139. Global Lung Cancer Genomic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Lung Cancer Genomic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Lung Cancer Genomic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Lung Cancer Genomic Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Lung Cancer Genomic Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Lung Cancer Genomic Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Lung Cancer Genomic Testing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Genomic Testing Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Genomic Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Genomic Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Genomic Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2024)
Table 10. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Lung Cancer Genomic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Genomic Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Lung Cancer Genomic Testing Sales by Type (K Units)
Table 26. Global Lung Cancer Genomic Testing Market Size by Type (M USD)
Table 27. Global Lung Cancer Genomic Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Lung Cancer Genomic Testing Sales Market Share by Type (2020-2025)
Table 29. Global Lung Cancer Genomic Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Lung Cancer Genomic Testing Market Size Share by Type (2020-2025)
Table 31. Global Lung Cancer Genomic Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Lung Cancer Genomic Testing Sales (K Units) by Application
Table 33. Global Lung Cancer Genomic Testing Market Size by Application
Table 34. Global Lung Cancer Genomic Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Lung Cancer Genomic Testing Sales Market Share by Application (2020-2025)
Table 36. Global Lung Cancer Genomic Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Lung Cancer Genomic Testing Market Share by Application (2020-2025)
Table 38. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Lung Cancer Genomic Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Lung Cancer Genomic Testing Sales Market Share by Region (2020-2025)
Table 41. Global Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Lung Cancer Genomic Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Lung Cancer Genomic Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Lung Cancer Genomic Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Lung Cancer Genomic Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Lung Cancer Genomic Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Lung Cancer Genomic Testing Production (K Units) by Region(2020-2025)
Table 54. Global Lung Cancer Genomic Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Lung Cancer Genomic Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Lung Cancer Genomic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. CD Genomics Basic Information
Table 62. CD Genomics Lung Cancer Genomic Testing Product Overview
Table 63. CD Genomics Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. CD Genomics Business Overview
Table 65. CD Genomics SWOT Analysis
Table 66. CD Genomics Recent Developments
Table 67. Qiagen NV Basic Information
Table 68. Qiagen NV Lung Cancer Genomic Testing Product Overview
Table 69. Qiagen NV Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Qiagen NV Business Overview
Table 71. Qiagen NV SWOT Analysis
Table 72. Qiagen NV Recent Developments
Table 73. Laboratory Corporation of America Holdings Basic Information
Table 74. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
Table 75. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Laboratory Corporation of America Holdings Business Overview
Table 77. Laboratory Corporation of America Holdings SWOT Analysis
Table 78. Laboratory Corporation of America Holdings Recent Developments
Table 79. NeoGenomics Laboratories Basic Information
Table 80. NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
Table 81. NeoGenomics Laboratories Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. NeoGenomics Laboratories Business Overview
Table 83. NeoGenomics Laboratories Recent Developments
Table 84. Agilent Technologies Inc. Basic Information
Table 85. Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
Table 86. Agilent Technologies Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Agilent Technologies Inc. Business Overview
Table 88. Agilent Technologies Inc. Recent Developments
Table 89. Illumina Inc. Basic Information
Table 90. Illumina Inc. Lung Cancer Genomic Testing Product Overview
Table 91. Illumina Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Illumina Inc. Business Overview
Table 93. Illumina Inc. Recent Developments
Table 94. Thermo Fischer Scientific Inc. Basic Information
Table 95. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
Table 96. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Thermo Fischer Scientific Inc. Business Overview
Table 98. Thermo Fischer Scientific Inc. Recent Developments
Table 99. Abbott Laboratories Inc. Basic Information
Table 100. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
Table 101. Abbott Laboratories Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Abbott Laboratories Inc. Business Overview
Table 103. Abbott Laboratories Inc. Recent Developments
Table 104. Quest Diagnostics Inc. Basic Information
Table 105. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
Table 106. Quest Diagnostics Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Quest Diagnostics Inc. Business Overview
Table 108. Quest Diagnostics Inc. Recent Developments
Table 109. OncoDNA Basic Information
Table 110. OncoDNA Lung Cancer Genomic Testing Product Overview
Table 111. OncoDNA Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. OncoDNA Business Overview
Table 113. OncoDNA Recent Developments
Table 114. Centogene N.V. Basic Information
Table 115. Centogene N.V. Lung Cancer Genomic Testing Product Overview
Table 116. Centogene N.V. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Centogene N.V. Business Overview
Table 118. Centogene N.V. Recent Developments
Table 119. Admera Health Basic Information
Table 120. Admera Health Lung Cancer Genomic Testing Product Overview
Table 121. Admera Health Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Admera Health Business Overview
Table 123. Admera Health Recent Developments
Table 124. CeGaT GmbH Basic Information
Table 125. CeGaT GmbH Lung Cancer Genomic Testing Product Overview
Table 126. CeGaT GmbH Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. CeGaT GmbH Business Overview
Table 128. CeGaT GmbH Recent Developments
Table 129. OPKO Health Inc. Basic Information
Table 130. OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
Table 131. OPKO Health Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. OPKO Health Inc. Business Overview
Table 133. OPKO Health Inc. Recent Developments
Table 134. F. Hoffmann-La Roche AG. Basic Information
Table 135. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
Table 136. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. F. Hoffmann-La Roche AG. Business Overview
Table 138. F. Hoffmann-La Roche AG. Recent Developments
Table 139. Global Lung Cancer Genomic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Lung Cancer Genomic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Lung Cancer Genomic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Lung Cancer Genomic Testing Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Lung Cancer Genomic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Lung Cancer Genomic Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Lung Cancer Genomic Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Lung Cancer Genomic Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Lung Cancer Genomic Testing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Genomic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Genomic Testing Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Genomic Testing Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Genomic Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Genomic Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Genomic Testing Product Life Cycle
Figure 13. Lung Cancer Genomic Testing Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Genomic Testing Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Genomic Testing
Figure 19. Global Lung Cancer Genomic Testing Market PEST Analysis
Figure 20. Global Lung Cancer Genomic Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Genomic Testing Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Genomic Testing by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Genomic Testing by Type in 2024
Figure 29. Market Size Share of Lung Cancer Genomic Testing by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Genomic Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Genomic Testing Market Share by Application
Figure 33. Global Lung Cancer Genomic Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Genomic Testing Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Genomic Testing Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Genomic Testing Market Share by Application in 2024
Figure 37. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Genomic Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Genomic Testing Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Genomic Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Genomic Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Genomic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Genomic Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Genomic Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Genomic Testing Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Genomic Testing Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Genomic Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Genomic Testing Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Genomic Testing Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Genomic Testing Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Genomic Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Genomic Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Genomic Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Genomic Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Genomic Testing Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Genomic Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Genomic Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Genomic Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Genomic Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Genomic Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Genomic Testing Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Lung Cancer Genomic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Genomic Testing Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Genomic Testing Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Genomic Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Genomic Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Genomic Testing Product Life Cycle
Figure 13. Lung Cancer Genomic Testing Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Genomic Testing Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Genomic Testing
Figure 19. Global Lung Cancer Genomic Testing Market PEST Analysis
Figure 20. Global Lung Cancer Genomic Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Genomic Testing Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Genomic Testing by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Genomic Testing by Type in 2024
Figure 29. Market Size Share of Lung Cancer Genomic Testing by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Genomic Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Genomic Testing Market Share by Application
Figure 33. Global Lung Cancer Genomic Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Genomic Testing Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Genomic Testing Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Genomic Testing Market Share by Application in 2024
Figure 37. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Genomic Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Genomic Testing Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Genomic Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Genomic Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Genomic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Genomic Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Genomic Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Genomic Testing Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Genomic Testing Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Genomic Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Genomic Testing Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Genomic Testing Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Genomic Testing Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Genomic Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Genomic Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Genomic Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Genomic Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Genomic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Genomic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Genomic Testing Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Genomic Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Genomic Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Genomic Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Genomic Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Genomic Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Genomic Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Genomic Testing Market Share Forecast by Application (2026-2033)
